NMP medical Research Institute
Jaipur, Rajastha, India
NCT Number: NCT01242592
The purpose of the study is to evaluate the effect of homeopathy as an adjuvant to Anti tuberculosis treatment on sputum conversion, hematological, clinical sign and symptoms of relapsed Pulmonary TB.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2
Jaipur, Rajastha, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
relapse pulmonary tuberculosis patients with acid-fast bacilli smear positive by microscopy, using ZiehlNieelsen staining as recommended by WHO, unfit for DOTS -
Exclusion criteria
pregnancy, clinical sign of any concomitant disease such as diabetes mellitus, acute renal failure or infectious disease including TB/HIV and HIV positive, currently or taken any alternative therapies in past 6 months
Other names: DOT CAT II
Sputum AFB status by microscopy will be recorded. Sputum conversion is defined as three consecutive sputum smears negative for AFB.
Quality of life assessed using SF 36 questionnaire 20 before treatment and after follow up of 11 months. Low numeric scores reflect a perception of poor health, loss of function, and presence of pain
NMP Medical Research Institute
Other
Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00694629
Actinomycetales Infections, Bacterial Infections
Little Rock, Arkansas, United States
View Trial DetailsNCT07595588
Actinomycetales Infections, Bacterial Infections
Hong Kong
View Trial DetailsNCT04930744
Actinomycetales Infections, Bacterial Infections
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT04666311
Abnormalities, Multiple, Actinomycetales Infections
Butha-Buthe, Lesotho
View Trial Details